Across TCGA pan-cancer cohorts, LRRC37A12P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LRRC37A12P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LRRC37A12P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LRRC37A12P is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

STAD, PRAD, and LUAD are the cancer types where LRRC37A12P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LRRC37A12P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.026	.037	3	view →
PRAD	All	All	−0.021	.049	2	view →
LUAD	Male	II,III,IV	+0.040	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LRRC37A12P RNA expression & survival · all LRRC37A12P data types